"Transplant has had a dramatic impact over the last 20+ years, but at the end of the day
we woefully provide care to the patients who need us.”
David Gerber, MD, Division Chief,
Abdominal Organ Transplantation
UNC-Chapel Hill, CMO-Smart Perfusion What Smart Perfusion has Learned About the Transplant Industry & Technology
The Competition
Potential competitors are using 10-20 year old technology.
- Current technology has not increased the number of transplants in two decades.
VasoWave™ Will Eliminate the Competition
VasoWave™ uses modern technology.
- Mimic of cardio and physiologic conditions
- Real-time electronics and redundancy to maintain perfusion
- State-of-the-Art electronics for tissue viability monitoring
- Organ physiology-based perfusion protocols
VasoWave™ doesn’t just replicate past technology - It’s supported by laboratory and pre-clincial validation.
This engineering and scientific diligence will protect Investor capital and enhance returns.
The Value of Transplantation With the VasoWave™ Systems
- $1.2B in the US each year
- $5.0B worldwide each year
- Value of each patient is $285K - $350K to the transplant/medical community that VasoWave™ enables is at least:
— $100K physician/hospital fees, pre-transplant
— $135K-$150K physician/hospital/nursing fees at transplant
— $50K-$100K outpatient/physician fees each year after transplant
The cost of lost productivity and individual lives lost to organ failure that VasoWave™ eliminates are estimated to be $50K - $250K per year per patient for over 100,000 patients! Learn about the VasoWave™ System.
Supplying Organ Transplants — A Medical Crisis
 |
|
 |